121 related articles for article (PubMed ID: 9665021)
1. One-way donor-recipient HLA-matching as a risk factor for graft-versus-host disease in living-related liver transplantation.
Kiuchi T; Harada H; Matsukawa H; Kasahara M; Inomata Y; Uemoto S; Asonuma K; Egawa H; Maruya E; Saji H; Tanaka K
Transpl Int; 1998; 11 Suppl 1():S383-4. PubMed ID: 9665021
[TBL] [Abstract][Full Text] [Related]
2. Fatal graft-versus-host disease after living donor liver transplantation: differential impact of donor-dominant one-way HLA matching.
Kamei H; Oike F; Fujimoto Y; Yamamoto H; Tanaka K; Kiuchi T
Liver Transpl; 2006 Jan; 12(1):140-5. PubMed ID: 16382466
[TBL] [Abstract][Full Text] [Related]
3. Fatal Graft-Versus-Host Disease Following Adult-To-Adult Living Donor Liver Transplantation From an HLA Nonhomozygous Donor.
Yu YD; Kim DS; Ha N; Jung SW; Han JH; Kim JY; Park SH; Cho YJ
Prog Transplant; 2016 Dec; 26(4):394-396. PubMed ID: 27555077
[TBL] [Abstract][Full Text] [Related]
4. Graft-versus-host disease following living donor liver transplantation.
Soejima Y; Shimada M; Suehiro T; Hiroshige S; Gondo H; Takami A; Yasue S; Maehara Y
Liver Transpl; 2004 Mar; 10(3):460-4. PubMed ID: 15004778
[TBL] [Abstract][Full Text] [Related]
5. Unusual onset of chronic graft-versus-host disease after adult living-related liver transplantation from a homozygous donor.
Nemoto T; Kubota K; Kita J; Shimoda M; Rokkaku K; Tagaya N; Fujiwara T; Sunakawa M
Transplantation; 2003 Mar; 75(5):733-6. PubMed ID: 12640319
[TBL] [Abstract][Full Text] [Related]
6. Fatal graft-versus-host disease after living-donor liver transplantation from an HLA-DR-mismatched donor.
Shimata K; Sakamoto R; Anan T; Uchida K; Honda M; Kouroki M; Urabe T; Hayashida S; Yamamoto H; Sugawara Y; Inomata Y
Pediatr Transplant; 2017 Nov; 21(7):. PubMed ID: 28834141
[TBL] [Abstract][Full Text] [Related]
7. Role of HLA compatibility in pediatric living-related liver transplantation.
Kasahara M; Kiuchi T; Uryuhara K; Uemoto S; Fujimoto Y; Ogura Y; Oike F; Kaihara S; Egawa H; Tanaka K
Transplantation; 2002 Oct; 74(8):1175-80. PubMed ID: 12438966
[TBL] [Abstract][Full Text] [Related]
8. Acute graft-versus-host disease after living donor liver transplantation with donor-dominant one-way human leukocyte antigen matching at two Loci.
Shimizu T; Hayashi M; Inoue Y; Komeda K; Asakuma M; Hirokawa F; Iwamoto M; Miyamoto Y; Yonetani N; Saji H; Haga H; Tanigawa N
Transplantation; 2010 May; 89(9):1164-6. PubMed ID: 20440198
[No Abstract] [Full Text] [Related]
9. Relevance of HLA compatibility in living donor liver transplantation: the double-edged sword associated with the patient outcome.
Uchiyama H; Kayashima H; Matono R; Shirabe K; Yoshizumi T; Ikegami T; Soejima Y; Matsuura T; Taguchi T; Maehara Y
Clin Transplant; 2012; 26(5):E522-9. PubMed ID: 23061761
[TBL] [Abstract][Full Text] [Related]
10. Transfusion-associated graft-versus-host disease in immunocompetent patients: report of a fatal case associated with transfusion of blood from a second-degree relative, and a survey of predisposing factors.
Petz LD; Calhoun L; Yam P; Cecka M; Schiller G; Faitlowicz AR; Herron R; Sayah D; Wallace RB; Belldegrun A
Transfusion; 1993 Sep; 33(9):742-50. PubMed ID: 8105567
[TBL] [Abstract][Full Text] [Related]
11. [One-way matching of HLA antigens between recipient and donor as a risk factor of transfusion-associated GVHD].
Takahashi K
Nihon Rinsho; 1997 Sep; 55(9):2240-5. PubMed ID: 9301283
[TBL] [Abstract][Full Text] [Related]
12. Acute graft versus host disease following living donor liver transplantation: first Korean report.
Cho EH; Suh KS; Yang SH; Lee HW; Cho JY; Cho YB; Yi NJ; Lee KU
Hepatogastroenterology; 2007; 54(79):2120-2. PubMed ID: 18251173
[TBL] [Abstract][Full Text] [Related]
13. Donor-dominant one-way matching of human leukocyte antigen-A/B/DR alleles predicts graft-versus-host disease following living donor liver transplantation.
Hirata M; Yagi S; Shindo T; Yoshizawa A; Kiguchi G; Kaneshiro M; Yurugi K; Miyachi Y; Iwamura S; Yao S; Uemoto S
Hepatol Res; 2021 Jan; 51(1):135-148. PubMed ID: 33034106
[TBL] [Abstract][Full Text] [Related]
14. Complete lymphoid chimerism and chronic graft-versus-host disease in an infant recipient of a hepatic allograft from an HLA-homozygous parental living donor.
Whitington PF; Rubin CM; Alonso EM; McKeithan TW; Anastasi J; Hart J; Thistlethwaite JR
Transplantation; 1996 Nov; 62(10):1516-9. PubMed ID: 8958284
[TBL] [Abstract][Full Text] [Related]
15. The clinical impact of donor against recipient HLA one way mismatch on the occurrence of graft versus host disease in liver transplantation.
Kim SJ; Park S; Rhu J; Kim JM; Choi GS; Joh JW
Sci Rep; 2022 Nov; 12(1):20337. PubMed ID: 36434131
[TBL] [Abstract][Full Text] [Related]
16. Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors.
Teshima T; Matsuo K; Matsue K; Kawano F; Taniguchi S; Hara M; Hatanaka K; Tanimoto M; Harada M; Nakao S; Abe Y; Wake A; Eto T; Takemoto Y; Imamura M; Takahashi S; Ishida Y; Kanda Y; Kasai M; Takaue Y
Br J Haematol; 2005 Aug; 130(4):575-87. PubMed ID: 16098073
[TBL] [Abstract][Full Text] [Related]
17. Role of the mixed lymphocyte culture (MLC) reaction in marrow donor selection: matching for transplants from related haploidentical donors.
Mickelson EM; Guthrie LA; Etzioni R; Anasetti C; Martin PJ; Hansen JA
Tissue Antigens; 1994 Aug; 44(2):83-92. PubMed ID: 7817382
[TBL] [Abstract][Full Text] [Related]
18. How is transfusion-associated graft-versus-host disease similar to, yet different from, organ transplantation-associated graft-versus-host disease?
Sato N; Marubashi S
Transfus Apher Sci; 2022 Apr; 61(2):103406. PubMed ID: 35283033
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for acute rejection in pediatric living related liver transplantation: the impact of HLA matching.
Sugawara Y; Mizuta K; Kawarasaki H; Takayama T; Imamura H; Makuuchi M
Liver Transpl; 2001 Sep; 7(9):769-73. PubMed ID: 11552209
[TBL] [Abstract][Full Text] [Related]
20. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
